Market Quick Take - May 19, 2020 Market Quick Take - May 19, 2020 Market Quick Take - May 19, 2020

Market Quick Take - May 19, 2020

Macro 3 minutes to read
Steen Jakobsen

Chief Investment Officer

Summary:  Equity markets closed to the cycle highs in the US yesterday after drug company Moderna claimed success in early trials with a Covid19 vaccine before the market open yesterday. In Europe, German Chancellor Merkel and French President Macron announced an agreement in principle on a half-trillion euro recovery deal to be funded by the EU, prompting a euro rally and supported Italian sovereign debt.

What is our trading focus?

  • US500.I (S&P 500 Index) and USNAS100.I (NASDAQ 100 Index) – US markets ripped higher yesterday, with much of the action coming before the US open on the announcement of a possible vaccine candidate from Moderna. The S&P had a look at the cycle highs at 2965 yesterday and the 200-day moving average is only slightly higher, just above 3000. The Nasdaq 100 index, meanwhile, managed to trade briefly above the highs for the cycle, posting a high of 9365 yesterday, less then 4.5% from an all-time high.
  • EURUSD and EURCHF– a possible watershed moment for the EU response to the Covid19 crisis yesterday came with the announcement of a crisis recovery fund from Merkel and Macron (more below) and the euro responded with a sharp rally against the USD and JPY. EURUSD closed the session yesterday at its highest level in two weeks, with the next focus, if the move can hold at the 1.1000 area highs from the beginning of the month. The EURCHF move above 1.0600 from near 1.0500 was also particularly large given the recent trading range there.
  • GBPUSD and EURGBP – sterling consolidated yesterday and rallied against a very weak US dollar but ended the day still near recent lows versus the euro after BoE member Tenreyro clearly indicated that negative policy rates are a policy option for the bank late Monday and said they had been a success in Europe. BoE Chief Economist Haldane also indicated the bank must study how low rates can go.
  • MRNA:xnas (Moderna) - shares were up 20% yesterday as biotechnology company announced positive news on its experimental vaccine for COVID-19 with signs of immune-system response. The phase 1 trial consisted of 45 patients, so we encourage investors to not get too excited yet. In the phase 2 trial 600 patients will be part of the experiment and thus being much more difficult to pass -false positives are part of phase 1 trials. The fact that Moderna also announced a public offering of $1.3bn just after the trial data release gives some indication that many of these vaccine companies are taking advantage of every opportunity to increase perception to raise funds either from private investors or get access to public funds.
  • XLE:arcx (US energy sector) and EXH1:xetr (European oil & gas sector) - with Brent crude pushing through $35/brl this morning our long thesis on energy companies (oil majors) from last week seems to have got some tailwind. The combination of oil demand from China, oil production cuts and general strong sentiment in equities are lifting both oil prices and energy stocks.
  • XAUUSD & XAGUSD – Gold’s climb to a fresh 7-year high has been met with profit taking after US stocks surged on renewed hopes for a coronavirus vaccine. Holdings in gold-backed ETFs meanwhile reached a fresh record of 3075 tons, a year-to-date increase of 500 tons. Support now needs to be found around the recent resistance-turned-support level at $1720/oz. Following Fed’s Powell comments that the coronavirus recovery could stretch through end of 2021 the market will be focusing on his appearance before the Senate Banking Committee today.
  • OILUSJUL20 and OILUKJUL20 – WTI and Brent crude oil have both reached one-month highs. Swift and aggressive production cuts from the OPEC+, rising demand, a V-shaped recovery in Chinese oil demand and news about a viable coronavirus vaccine have all supported to current recovery. The recent rally and with that the collapse in time spreads should see storage plays begin to be abandoned thereby adding supply to be the market. The biggest short-term risk however remains the risk of producers beginning to waver on maintaining cuts, especially in the US with forward prices now well above $30/b. Resistance in WTI at $35/b and Brent at $36.3/b.

What is going on?

Germany and France agree on recovery deal of EUR 500 billion, which would be funded from the EU budget (the MFF) and weighted by the capital key (i.e., Germany would fund a significant percentage of the package as the largest EU economy), but with funds directed in the form of grants and weighted to countries most affected by the Covid19 outbreak. The idea must be approved by all 27 EU member states, but it is seen as a significant breakthrough. The Euro rallied sharply, and Italy-Germany 10-year debt spreads fell some 25 basis points.

US President Trump threatened to pull the US out of the WHO permanently if changes were not made to the organization to prevent what the US sees as its pro-China bias.

China moved ahead with tariffs of 80% against imports of Australian barley, a move seen in retaliation for Australia’s questioning of the origins of the coronavirus even if China claimed the move was against Australian dumping of barley hurting its domestic production. The AUD was slightly lower in the crosses, but still managed a strong day yesterday against safe-haven currencies. China is said to be considering move against Australia’s wine and dairy industries.

China has moved to lockdown some 100 million of its population in Northeastern regions of China on a second wave outbreak of Covid19.

What we are watching next?

US Secretary of Treasury Mnuchin and Fed Chair Powell to testify today before a Senate banking committee on the CARES act, as the political scene in the US is heating up ahead of the 2020 election in early November. Discord between the two parties could hamper the further response from the US government as a huge $3 trillion house bill passed by the democratic majority body will not pass the Republican majority Senate or receive President Trump’s signature.

Economic Calendar Highlights (times GMT)

  • 0815 – Norway Norges Bank chief Olsen to Speak - with the Norwegian government stepping up big with a large stimulus announcement recently and oil prices on the mend, the Norwegian Central Bank may see little urgency at the moment to send any loud signals.
  • 0900 – Germany May ZEW Survey – Germany is at the leading edge of economies trying to open up from Covid19 shutdowns, as we watch for the shape of the recovery from here.
  • 1230 – US Apr. Housing Starts and Building Permits – rearview mirror data from what we all know was the month of total shutdown.
  • 1400 – US Fed Chair Powell and US Treasury Secretary Mnuchin to testify.


Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher


The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.